Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Sangamo Therapeutics (NQ: SGMO )

15.75 USD -0.44 (-2.72%)
Official Closing Price Updated: 7:58 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Sangamo Therapeutics

< Previous 1 2 3 4 5 6 7 8 9
...
57 58 Next >
The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ABCL IBB AVIR
From Benzinga
Sangamo Therapeutics Announces Departure of Chief Financial Officer Sung Lee
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Chief Financial Officer Sung Lee is leaving the Company to pursue a new opportunity overseas. Mr. Lee’s last... 
From Business Wire News Releases
Benzinga's Top Upgrades, Downgrades For January 6, 2021
Upgrades For Regenxbio Inc (NASDAQ:RGNX), Raymond James upgraded the previous rating of Outperform to Strong Buy. For ... 
Tags SEIC BRBR NSTG
From Benzinga
Sangamo Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present a corporate overview at the 39th Annual J.P. Morgan Healthcare Conference on... 
From Business Wire News Releases
The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags EW AMPH PRAX
From Benzinga
My “Trade Ideas Special” edition for the last week of 2020
Tags MARA OCG IPOC
From AC Investor Blog
The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags FDA BPMC ATRC
From Benzinga
88 Biggest Movers From Yesterday
Gainers Ocugen Inc (NASDAQ: OCGN) shares surged 173.9% to close at $0.8052 on Tuesday after the company and Bharat Biotech ... 
Tags PTAC Communications Equipment BRPA
From Benzinga
Sangamo Therapeutics Scores Relative Strength Rating Upgrade
Sangamo Therapeutics sees its Relative Strength Rating hit the elite 90-plus level. 
From Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Ocugen (NASDAQ:OCGN) stock moved upwards by 141.83% to $0.71 during Tuesday's regular session. As of 12:31 ... 
Tags Top Gainers NH Markets
From Benzinga
61 Stocks Moving In Tuesday's Mid-Day Session
Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares jumped 202% to $74.37 after jumping over 60% on Monday. Ocugen ... 
Tags EYES CYCC AMTX
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
During Tuesday's morning session, 342 companies made new 52-week highs. Intriguing Points: The largest company by ... 
Tags WRAP SEEL RDFN
From Benzinga
The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags VTGN CMPI CRTX
From Benzinga
42 Stocks Moving in Tuesday's Pre-Market Session
Gainers Aurora Mobile Limited (NASDAQ: JG) shares rose 56.4% to $4.99 in pre-market trading after the company reported a ... 
Tags EYEG Benzinga Markets
From Benzinga
Notable Monday Option Activity: SGMO, PENN, ZS
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Sangamo Therapeutics Inc (SGMO), where a total of 16,270 contracts have traded so far,... 
Tags Stocks
From Market News Video
First Week of SGMO August 2021 Options Trading
Investors in Sangamo Therapeutics Inc (SGMO) saw new options become available this week, for the August 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to... 
Tags Stocks
From Market News Video
If You Invested $5,000 in Pfizer In January, Here's How Much You'd Have Now
Shares didn't benefit much from the pharma's efforts to help to save humanity. 
Tags VTRS SGMO Market News
From Motley Fool
Stocks To Watch: Sangamo Therapeutics Sees RS Rating Rise To 85
Sangamo Therapeutics sees its Relative Strength Rating hit the 80-plus level. 
From Investor's Business Daily
72 Biggest Movers From Friday
Gainers AbCellera Biologics Inc. (NASDAQ: ABCL) shares jumped 194.5% to close at $58.90 after the company priced its IPO at $20 ... 
Tags SNOA APOP AESE
From Benzinga
Should Investors Be Watching These Biotech Stocks Going Into 2021? 2 Up 300%+ Since March
From Stockmarket.com
60 Stocks Moving In Friday's Mid-Day Session
Gainers TPG Pace Beneficial Finance Corp. (NYSE: TPGY) shares jumped 111.5% to $23.48 on a merger deal with EV charging company ... 
Tags ALXO News TCDA
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags IPHA SIBN XERS
From Benzinga
84 Biggest Movers From Yesterday
Gainers SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) shares climbed 176.4% to close at $17.66 on Thursday after climbing 73% on ... 
Tags AQB TTGT PRLD
From Benzinga
Noteworthy Thursday Option Activity: TWNK, OKTA, SGMO
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Hostess Brands Inc (TWNK), where a total of 9,996 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels in 3x1013 VG/KG Cohort Through One Year Following Hemophilia A Gene Therapy
Pfizer Inc. (NYSE: PFE) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced updated follow-up data from the Phase 1/2 Alta study of giroctocogene fitelparvovec... 
From Business Wire News Releases
Cramer Advises Viewers On Ballard Power Systems, Blink Charging And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he would wait to buy Ballard Power Systems Inc (NASDAQ: BLDP). The ... 
Tags Market News PCG CNBC
From Benzinga
This Company's New Approach Could Slash Gilead's Profit From HIV Drugs
The company's HIV franchise faces threats from many different directions. 
Tags GILD TEVA Market News
From Motley Fool
Look Under The Hood: PBE Has 22% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Sangamo Therapeutics Sees IBD RS Rating Improve To 73
Sangamo Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the following investor conferences: 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
57 58 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.